Tesetaxel as Second-line Therapy for Patients With Advanced Melanoma and Normal Serum LDH
Clinical trial NCT01092585 · UNKNOWN
Trial details
- NCT number
- NCT01092585
- Sponsor
- Genta Incorporated
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-02-01
- Primary completion
- 2012-03-01
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.